{"id":75038,"date":"2023-10-26T17:04:30","date_gmt":"2023-10-26T21:04:30","guid":{"rendered":"https:\/\/hitconsultant.net\/?p=75038"},"modified":"2023-10-26T17:04:32","modified_gmt":"2023-10-26T21:04:32","slug":"georgiamune-and-verily-partner-cancer-treatment","status":"publish","type":"post","link":"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/","title":{"rendered":"Georgiamune and Verily Partner to Advance Novel Cancer Treatment"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

What You Should Know:<\/strong><\/p>\n\n\n\n

– Georgiamune<\/a>, a privately held, clinical stage biotechnology<\/a> company, and Verily<\/a>, an Alphabet precision health technology company forms a strategic partnership to advance novel therapeutics for patients with cancer.<\/p>\n\n\n\n

– Through this partnership, Verily and Georgimune will focus on identifying the patient population that could potentially benefit the most from Georgiamune\u2019s GIM-122, a first-in-class dual-functioning antibody that has the potential to help patients with advanced solid tumors who have not responded to current treatments with a checkpoint inhibitor.<\/p>\n\n\n\n

Integrating Clinical Trial Data and Longitudinal Real-World Data Sources<\/strong><\/p>\n\n\n\n

The two companies will also focus on driving more efficient clinical development by incorporating clinical trial data and longitudinal real-world data sources. The collaboration innovates how clinical trials are currently conducted by bringing together different data modalities to identify the patient populations most likely to benefit from Georgiamune\u2019s novel therapy and by providing a more holistic analysis of how participants are responding to the therapy over time.<\/p>\n\n\n\n

The partners will implement immune mapping with Verily\u2019s Immune Profiler for GIM-122, a first-in-class dual-functioning antibody currently being evaluated for safety, tolerability, and antitumor activity in a first-in-human, phase 1\/2 clinical trial in adults with checkpoint refractory or resistant advanced solid tumor malignancies. Georgiamune will utilize Immune Profiler to assess the pharmacodynamic effect of GIM-122 and interrogate the immune response of patients. As part of the partnership, the two companies will also aim to expand into other assets developed by Georgiamune in cancer and other therapeutic areas, including autoimmune diseases. <\/p>\n\n\n\n

\u201cGeorgiamune is a cutting edge innovation company with groundbreaking scientific discoveries leading to first and best in class immune therapies for cancer and autoimmune diseases,\u201d said Georgiamune\u2019s Founder and Chief Executive Officer Dr. Samir N. Khleif. \u201cVerily\u2019s expertise in immune profiling, real-world data, and advanced analytics provide a comprehensive data profile to accelerate development of our novel drug candidate. This partnership will allow us to focus on identifying the patient population that could potentially benefit the most from our breakthrough discoveries.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"

What You Should Know: – Georgiamune, a privately held, clinical stage biotechnology company, and Verily, an Alphabet precision health technology company forms a strategic partnership to advance novel therapeutics for patients with cancer. – Through this partnership, Verily and Georgimune will focus on identifying the patient population that could potentially benefit the most from Georgiamune\u2019s … Read More<\/a><\/p>\n","protected":false},"author":4,"featured_media":75039,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"categories":[25444],"tags":[2581],"yoast_head":"\nGeorgiamune and Verily Partner to Advance Novel Cancer Treatment<\/title>\n<meta name=\"description\" content=\"Georgiamune and Verily forms a strategic partnership to advance novel therapeutics for patients with cancer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Georgiamune and Verily Partner to Advance Novel Cancer Treatment\" \/>\n<meta property=\"og:description\" content=\"Georgiamune and Verily forms a strategic partnership to advance novel therapeutics for patients with cancer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pages\/HIT-Consultant-Media\/302199219847409\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-26T21:04:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-26T21:04:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hitconsultant.net\/wp-content\/uploads\/2023\/10\/62bedae3c9911e245a0f9bd9_home-image-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1374\" \/>\n\t<meta property=\"og:image:height\" content=\"1030\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jasmine Pennic\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hitconsultant\" \/>\n<meta name=\"twitter:site\" content=\"@hitconsultant\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jasmine Pennic\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/\"},\"author\":{\"name\":\"Jasmine Pennic\",\"@id\":\"https:\/\/hitconsultant.net\/#\/schema\/person\/0f8ab4dc187dabf6ac3738e24d381f66\"},\"headline\":\"Georgiamune and Verily Partner to Advance Novel Cancer Treatment\",\"datePublished\":\"2023-10-26T21:04:30+00:00\",\"dateModified\":\"2023-10-26T21:04:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/\"},\"wordCount\":343,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/hitconsultant.net\/#organization\"},\"keywords\":[\"Oncology\"],\"articleSection\":[\"Life Sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/\",\"url\":\"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/\",\"name\":\"Georgiamune and Verily Partner to Advance Novel Cancer Treatment\",\"isPartOf\":{\"@id\":\"https:\/\/hitconsultant.net\/#website\"},\"datePublished\":\"2023-10-26T21:04:30+00:00\",\"dateModified\":\"2023-10-26T21:04:32+00:00\",\"description\":\"Georgiamune and Verily forms a strategic partnership to advance novel therapeutics for patients with cancer.\",\"breadcrumb\":{\"@id\":\"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/hitconsultant.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Life Sciences\",\"item\":\"https:\/\/hitconsultant.net\/category\/life-sciences\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Georgiamune and Verily Partner to Advance Novel Cancer Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/hitconsultant.net\/#website\",\"url\":\"https:\/\/hitconsultant.net\/\",\"name\":\"\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/hitconsultant.net\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/hitconsultant.net\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/hitconsultant.net\/#organization\",\"name\":\"HIT Consultant Media\",\"url\":\"https:\/\/hitconsultant.net\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/hitconsultant.net\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/hitconsultant.net\/wp-content\/uploads\/2012\/08\/hit_consultant_logo.png\",\"contentUrl\":\"https:\/\/hitconsultant.net\/wp-content\/uploads\/2012\/08\/hit_consultant_logo.png\",\"width\":\"1024\",\"height\":\"772\",\"caption\":\"HIT Consultant Media\"},\"image\":{\"@id\":\"https:\/\/hitconsultant.net\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/pages\/HIT-Consultant-Media\/302199219847409\",\"https:\/\/twitter.com\/hitconsultant\",\"http:\/\/www.linkedin.com\/company\/2489253\",\"https:\/\/www.pinterest.com\/hitconsultant\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/hitconsultant.net\/#\/schema\/person\/0f8ab4dc187dabf6ac3738e24d381f66\",\"name\":\"Jasmine Pennic\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/hitconsultant.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/540783d0e72e885fa97496c3f804346c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/540783d0e72e885fa97496c3f804346c?s=96&d=mm&r=g\",\"caption\":\"Jasmine Pennic\"},\"description\":\"Jasmine is a seasoned marketing and communication professional with more than seven years of experience in writing press releases, editing, strategic and content planning, marketing campaigns, and social media marketing.\",\"url\":\"https:\/\/hitconsultant.net\/author\/jpennic\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Georgiamune and Verily Partner to Advance Novel Cancer Treatment","description":"Georgiamune and Verily forms a strategic partnership to advance novel therapeutics for patients with cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/","og_locale":"en_US","og_type":"article","og_title":"Georgiamune and Verily Partner to Advance Novel Cancer Treatment","og_description":"Georgiamune and Verily forms a strategic partnership to advance novel therapeutics for patients with cancer.","og_url":"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/","article_publisher":"https:\/\/www.facebook.com\/pages\/HIT-Consultant-Media\/302199219847409","article_published_time":"2023-10-26T21:04:30+00:00","article_modified_time":"2023-10-26T21:04:32+00:00","og_image":[{"url":"https:\/\/hitconsultant.net\/wp-content\/uploads\/2023\/10\/62bedae3c9911e245a0f9bd9_home-image-1.png","width":1374,"height":1030,"type":"image\/png"}],"author":"Jasmine Pennic","twitter_card":"summary_large_image","twitter_creator":"@hitconsultant","twitter_site":"@hitconsultant","twitter_misc":{"Written by":"Jasmine Pennic","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/#article","isPartOf":{"@id":"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/"},"author":{"name":"Jasmine Pennic","@id":"https:\/\/hitconsultant.net\/#\/schema\/person\/0f8ab4dc187dabf6ac3738e24d381f66"},"headline":"Georgiamune and Verily Partner to Advance Novel Cancer Treatment","datePublished":"2023-10-26T21:04:30+00:00","dateModified":"2023-10-26T21:04:32+00:00","mainEntityOfPage":{"@id":"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/"},"wordCount":343,"commentCount":0,"publisher":{"@id":"https:\/\/hitconsultant.net\/#organization"},"keywords":["Oncology"],"articleSection":["Life Sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/","url":"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/","name":"Georgiamune and Verily Partner to Advance Novel Cancer Treatment","isPartOf":{"@id":"https:\/\/hitconsultant.net\/#website"},"datePublished":"2023-10-26T21:04:30+00:00","dateModified":"2023-10-26T21:04:32+00:00","description":"Georgiamune and Verily forms a strategic partnership to advance novel therapeutics for patients with cancer.","breadcrumb":{"@id":"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/hitconsultant.net\/2023\/10\/26\/georgiamune-and-verily-partner-cancer-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hitconsultant.net\/"},{"@type":"ListItem","position":2,"name":"Life Sciences","item":"https:\/\/hitconsultant.net\/category\/life-sciences\/"},{"@type":"ListItem","position":3,"name":"Georgiamune and Verily Partner to Advance Novel Cancer Treatment"}]},{"@type":"WebSite","@id":"https:\/\/hitconsultant.net\/#website","url":"https:\/\/hitconsultant.net\/","name":"","description":"","publisher":{"@id":"https:\/\/hitconsultant.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hitconsultant.net\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/hitconsultant.net\/#organization","name":"HIT Consultant Media","url":"https:\/\/hitconsultant.net\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hitconsultant.net\/#\/schema\/logo\/image\/","url":"https:\/\/hitconsultant.net\/wp-content\/uploads\/2012\/08\/hit_consultant_logo.png","contentUrl":"https:\/\/hitconsultant.net\/wp-content\/uploads\/2012\/08\/hit_consultant_logo.png","width":"1024","height":"772","caption":"HIT Consultant Media"},"image":{"@id":"https:\/\/hitconsultant.net\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pages\/HIT-Consultant-Media\/302199219847409","https:\/\/twitter.com\/hitconsultant","http:\/\/www.linkedin.com\/company\/2489253","https:\/\/www.pinterest.com\/hitconsultant\/"]},{"@type":"Person","@id":"https:\/\/hitconsultant.net\/#\/schema\/person\/0f8ab4dc187dabf6ac3738e24d381f66","name":"Jasmine Pennic","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hitconsultant.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/540783d0e72e885fa97496c3f804346c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/540783d0e72e885fa97496c3f804346c?s=96&d=mm&r=g","caption":"Jasmine Pennic"},"description":"Jasmine is a seasoned marketing and communication professional with more than seven years of experience in writing press releases, editing, strategic and content planning, marketing campaigns, and social media marketing.","url":"https:\/\/hitconsultant.net\/author\/jpennic\/"}]}},"_links":{"self":[{"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/posts\/75038"}],"collection":[{"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/comments?post=75038"}],"version-history":[{"count":0,"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/posts\/75038\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/media\/75039"}],"wp:attachment":[{"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/media?parent=75038"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/categories?post=75038"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/tags?post=75038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}